Devalingam Mahalingam, Rachna T. Shroff, Benedito A. Carneiro, Yan Ji, Andrew L. Coveler, Andres Cervantes, Vaibhav Sahai, Anne Ploquin, Sandrine Hiret, Noelle K. LoConte, Ivor John Percent, Charles D. Lopez, Simon Pernot, Petr Kavan, Mary Frances Mulcahy, Ryan Michael Carr, Francis J. Giles, Andrew Paul Mazar, Mark Jaros, Tanios S. Bekaii-Saab. "Results from the randomized phase 2 study (1801 Part 3B) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) versus GnP in previously untreated metastatic pancreatic ductal adenocarcinoma (mPDAC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.653